Ercros Cash Flow Conversion Efficiency
Ercros cash flow conversion efficiency. Based on the latest financial reports, Ercros (ECR) has a cash flow conversion efficiency ratio of 0.130x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€38.91 Million ≈ $45.49 Million USD) by net assets (€298.23 Million ≈ $348.66 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Ercros (2004–2025)
Cash flow conversion efficiency of Ercros from 2004 to 2025. This chart illustrates how Ercros's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Ercros (ECR) share price today for real-time trading data and today's change.
Ercros Cash Flow Conversion Ratio Explained
Ercros cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Ercros Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Ercros ranked by their cash flow conversion efficiency. Also see ECR company net worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Hubei Guochuang Hi-tech Material Co Ltd
SHE:002377
|
-0.092x |
|
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd
SHG:600671
|
-0.202x |
|
Pollard Banknote Limited
TO:PBL
|
0.007x |
|
Suzhou Fushilai Pharmaceutical Co. Ltd.
SHE:301258
|
N/A |
|
Build-A-Bear Workshop Inc
NYSE:BBW
|
0.031x |
|
AnHui Annada Titanium Industry Co Ltd
SHE:002136
|
0.022x |
|
TECHPOINT INC. JDR/1
F:R46
|
N/A |
|
Wave Cyber Shanghai Co Ltd
SHG:688718
|
0.028x |
Annual Cash Flow Conversion Efficiency for Ercros (2004–2025)
The table below shows the annual cash flow conversion efficiency of Ercros from 2004 to 2025. Review free cash flow generation of Ercros to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €298.23 Million ≈ $348.66 Million |
€49.19 Million ≈ $57.51 Million |
0.165x | +491.42% |
| 2024-12-31 | €341.16 Million ≈ $398.85 Million |
€9.51 Million ≈ $11.12 Million |
0.028x | -80.20% |
| 2023-12-31 | €363.12 Million ≈ $424.52 Million |
€51.14 Million ≈ $59.79 Million |
0.141x | -19.35% |
| 2022-12-31 | €360.71 Million ≈ $421.71 Million |
€62.99 Million ≈ $73.64 Million |
0.175x | -4.01% |
| 2021-12-31 | €331.61 Million ≈ $387.69 Million |
€60.32 Million ≈ $70.53 Million |
0.182x | -30.69% |
| 2020-12-31 | €284.21 Million ≈ $332.28 Million |
€74.59 Million ≈ $87.20 Million |
0.262x | +28.98% |
| 2019-12-31 | €292.08 Million ≈ $341.48 Million |
€59.43 Million ≈ $69.48 Million |
0.203x | +23.63% |
| 2018-12-31 | €272.67 Million ≈ $318.78 Million |
€44.88 Million ≈ $52.46 Million |
0.165x | -7.03% |
| 2017-12-31 | €247.49 Million ≈ $289.34 Million |
€43.81 Million ≈ $51.22 Million |
0.177x | -0.09% |
| 2016-12-31 | €219.83 Million ≈ $257.00 Million |
€38.95 Million ≈ $45.54 Million |
0.177x | +122.59% |
| 2015-12-31 | €175.88 Million ≈ $205.62 Million |
€14.00 Million ≈ $16.37 Million |
0.080x | -52.27% |
| 2014-12-31 | €168.19 Million ≈ $196.63 Million |
€28.05 Million ≈ $32.79 Million |
0.167x | +20.37% |
| 2013-12-31 | €172.21 Million ≈ $201.33 Million |
€23.86 Million ≈ $27.89 Million |
0.139x | +25.67% |
| 2012-12-31 | €173.87 Million ≈ $203.27 Million |
€19.17 Million ≈ $22.41 Million |
0.110x | +79.08% |
| 2011-12-31 | €187.11 Million ≈ $218.75 Million |
€11.52 Million ≈ $13.47 Million |
0.062x | +211.86% |
| 2010-12-31 | €192.23 Million ≈ $224.74 Million |
€-10.58 Million ≈ $-12.37 Million |
-0.055x | -127.63% |
| 2009-12-31 | €205.38 Million ≈ $240.11 Million |
€40.91 Million ≈ $47.83 Million |
0.199x | +107.53% |
| 2008-12-31 | €257.20 Million ≈ $300.69 Million |
€-680.00 Million ≈ $-794.99 Million |
-2.644x | -3972.47% |
| 2007-12-31 | €463.14 Million ≈ $541.46 Million |
€31.62 Million ≈ $36.97 Million |
0.068x | +269.03% |
| 2006-12-31 | €359.97 Million ≈ $420.84 Million |
€-14.54 Million ≈ $-17.00 Million |
-0.040x | -1477.60% |
| 2005-12-31 | €253.87 Million ≈ $296.80 Million |
€-650.00K ≈ $-759.92K |
-0.003x | +98.43% |
| 2004-12-31 | €95.06 Million ≈ $111.14 Million |
€-15.51 Million ≈ $-18.13 Million |
-0.163x | -- |
About Ercros
Ercros, S.A., together with its subsidiaries, manufactures and sells chemical and pharmaceutical products in Spain and internationally. It operates through three segments: Chlorine Derivatives, Intermediate Chemicals, and Pharmaceuticals. The company offers ammonia, caustic soda and potash, chlorine chloroisocyanurates, dichloroethane, ercrosbio, hydrochloric acid, hydrogen peroxide, polyvinyl ch… Read more